Friday, November 7, 2008

New Sudden Cardiac Death Database To Save Lives, UK

A database launched today will help identify the incidence and causes of sudden cardiac death and save the lives of people who may currently be at risk from the inherited heart condition that can strike without warning, the Department of Health announced today. Continue reading ...

Wild migratory birds may be more important carriers of avian influenza viruses from continent to continent than previously thought, according to new scientific research that has important implications for highly pathogenic avian influenza virus surveillance in North America. As part of a multi-pronged research effort to understand the role of migratory birds in the transfer of avian influenza viruses between Asia and North America, scientists with the U.S. Geological Survey (USGS), in collaboration with the U.S. Fish and Wildlife Service in Alaska and the University of Tokyo, have found genetic evidence for the movement of Asian forms of avian influenza to Alaska by northern pintail ducks. Continue reading ...

Plethora Solutions Holdings PLC ("Plethora" or the "Company", AIM: PLE), the specialist developer of products for the treatment and management of urological disorders, announces that its European Phase III double-blind placebo controlled study of PSD502 for the treatment of premature ejaculation (PE) has met its three co-primary endpoints of Intra-vaginal Ejaculation Latency Time ('IELT') and Index of Premature Ejaculation ('IPE'; Ejaculatory Control and Sexual Satisfaction domains). Continue reading ...

Vermed, a manufacturer of quality cardiac monitoring and diagnostic electrodes, introduces a new line of Defibrillation Pads with features new and unique to the market. Vermed pads use a new Universal Connector System (UCS) that allows standardization of the defib pads throughout any facility. This is a tremendous step toward patient safety and industry compliance. Continue reading ...

BTG plc (LSE:BGC), the life sciences company, announces that the full results of the US phase II safety study of Varisolve® are being presented today at the American College of Phlebology (ACP) 22nd Annual Congress. The results confirm that treatment with Varisolve® in subjects with right-to-left (R-L) cardiac shunts, which may allow residual bubbles following treatment to enter the cerebral arterial circulation, does not cause cerebral injury. Continue reading ...

For most patients with chronic kidney disease (CKD), the risk of experiencing a cardiovascular related death is greater than the risk of progressing to end-stage renal disease (ESRD). Continue reading ...

1 comments:

nigelthomas said...

Great article. We need to keep pandemic preparedness at the forefront of every business manager's mind. It won't go away so better start preparing.

For free references, resources and to join their free pandemic preparedness eCourse certification program, go to Bird Flu Manual Online or, if you need more comprehensive tutorials, tools and templates, consider Bird Flu D-I-Y eManual for your pandemic planning.